XML 32 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Deficit and Employee Benefit Plans
6 Months Ended
Jun. 30, 2017
Retirement Benefits [Abstract]  
Stockholders' Deficit and Employee Benefit Plans
Stockholders' Deficit and Employee Benefit Plans
Stock Based Compensation
We have stock-based compensation programs under which we use stock options and RSUs. In 2016, our stockholders approved the adoption of a new ESPP. The first offering period under the new ESPP commenced on January 1, 2017. The following reflects total stock-based compensation expense recognized under all programs:
 
Three Months Ended
 
Six Months Ended
June 30,
 
June 30,
2017
 
2016
 
2017
 
2016
Related to vesting of stock options
$
1.3

 
$
0.6

 
$
1.5

 
$
1.3

Related to vesting of RSUs
5.8

 
5.4

 
11.5

 
11.2

   Total
$
7.1

 
$
6.0

 
$
13.0

 
$
12.5


Employee Benefit Plans
We have defined benefit pension plans for our U.K.-based union employees (the "U.K. Plan") and certain Canadian-based employees (the "Canadian Plan") as well as a 401(k) plan for U.S.-based employees, which are described in Note 19 in our 2016 10-K. We recognized no material costs in 2017 and 2016 under these plans.

Series C Junior Participating Preferred Stock and Rights Agreement
On June 19, 2017, the Board of Directors of SGC approved, and SGC entered into, a Rights Agreement between SGC and American Stock Transfer & Trust Company, LLC. Concurrently, the Board of Directors of SGC adopted a resolution reserving for issuance a series of 20,000 shares of preferred stock, par value $1.00 per share, designated as Series C Junior Participating Preferred Stock ("Junior Preferred Stock") upon the exercise of rights under the Rights Agreement. The Rights Agreement provides for a dividend of one preferred share purchase right (“Right”) for each share of Class A Common Stock, par value $0.01 per share, of SGC outstanding as of June 29, 2017. Each Right entitles the holder to purchase from SGC one ten-thousandth of a share of Junior Preferred Stock for a purchase price of $109.00 , subject to adjustment as provided in the Rights Agreement. As of June 30, 2017, none of these shares were outstanding and no Rights were exercised.